<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14709</article-id><article-id pub-id-type="doi">10.7554/eLife.14709</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Kinase-dead ATM protein is highly oncogenic and can be preferentially targeted by Topo-isomerase I inhibitors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-51372"><name><surname>Yamamoto</surname><given-names>Kenta</given-names></name><aff><institution content-type="dept">Insitute for Cancer Genetics</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51373"><name><surname>Wang</surname><given-names>Jiguang</given-names></name><aff><institution content-type="dept">Department of Biomedical Informatics and Department of Systems Biology, , College of Physicians &amp; Surgeons</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51379"><name><surname>Sprinzen</surname><given-names>Lisa</given-names></name><aff><institution content-type="dept">Insitute for Cancer Genetics</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51374"><name><surname>Xu</surname><given-names>Jun</given-names></name><aff><institution content-type="dept">Skaggs School of Pharmacy &amp; Pharmaceutical Sciences</institution>, <institution>University of California San Diego</institution>, <addr-line><named-content content-type="city">San Diego</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51375"><name><surname>Haddock</surname><given-names>Christopher J</given-names></name><aff><institution content-type="dept">Edward A. Doisy Department of Biochemistry and Molecular Biology</institution>, <institution>Saint Louis University School of Medicine</institution>, <addr-line><named-content content-type="city">St. Louis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51376"><name><surname>Li</surname><given-names>Chen</given-names></name><aff><institution content-type="dept">Insitute for Cancer Genetics</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51377"><name><surname>Lee</surname><given-names>Brian J</given-names></name><aff><institution content-type="dept">Insitute for Cancer Genetics</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51378"><name><surname>Loredan</surname><given-names>Denis G</given-names></name><aff><institution content-type="dept">Insitute for Cancer Genetics</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-57123"><name><surname>Jiang</surname><given-names>Wenxia</given-names></name><aff><institution content-type="dept">Institute for Cancer Genetics</institution>, <institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51380"><name><surname>Vindigni</surname><given-names>Alessandro</given-names></name><aff><institution content-type="dept">Edward A. Doisy Department of Biochemistry and Molecular Biology</institution>, <institution>Saint Louis University School of Medicine</institution>, <addr-line><named-content content-type="city">St. Louis</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18885"><name><surname>Wang</surname><given-names>Dong</given-names></name><aff><institution content-type="dept">Skaggs School of Pharmacy &amp;amp; Pharmaceutical Sciences</institution>, <institution>University of California San Diego</institution>, <addr-line><named-content content-type="city">La Jolla</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-51381"><name><surname>Rabadan</surname><given-names>Raul</given-names></name><aff><institution content-type="dept">Department of Biomedical Informatics and Department of Systems Biology, College of Physicians &amp; Surgeons</institution>, <institution>Columbia Unviersity</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-50178"><name><surname>Zha</surname><given-names>Shan</given-names></name><aff><institution content-type="dept">Institute for Cancer Genetics</institution>, <institution>Columbia University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country><email>sz2296@cumc.columbia.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1199"><name><surname>Walter</surname><given-names>Johannes</given-names></name><role>Reviewing editor</role><aff><institution>Harvard Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>06</month><year>2016</year></pub-date><elocation-id>e14709</elocation-id><supplementary-material><ext-link xlink:href="elife-14709-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>26</day><month>01</month><year>2016</year></date><date date-type="accepted"><day>14</day><month>06</month><year>2016</year></date></history><permissions><copyright-statement>Â© 2016, Yamamoto et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Yamamoto et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Missense mutations in ATM kinase, a master regulator of DNA damage responses, are found in many cancers, but their impact on ATM function and implications for cancer therapy are largely unknown. Here we report that 72% of cancer-associated ATM mutations are missense mutations that are enriched around the kinase domain. Expression of kinase-dead ATM (<italic>Atm</italic><sup>KD/-</sup>) is more oncogenic than loss of ATM (<italic>Atm</italic><sup>-/-</sup>) in mouse models, leading to earlier and more frequent lymphomas with Pten deletions. Kinase-dead ATM protein (Atm-KD), but not loss of ATM (Atm-null), prevents replication-dependent removal of Topo-isomerase I-DNA adducts at the step of strand cleavage, leading to severe genomic instability and hypersensitivity to Topo-isomerase I inhibitors. Correspondingly, Topo-isomerase I inhibitors effectively and preferentially eliminate <italic>Atm</italic><sup>KD/-</sup>, but not Atm-proficient or <italic>Atm</italic><sup>-/-</sup> leukemia in animal models. These findings identify ATM kinase-domain missense mutations as a potent oncogenic event and a biomarker for Topo-isomerase I inhibitor based therapy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All the animal work was approved by and performed according to the regulations of the Institutional Animal Care and Use Committee (IACUC) of Columbia University (protocol no AAAF7653, AAAD6250, AAAJ3651)</p></fn></fn-group></back></article>